EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bacteroides uniformis Ameliorates Carbohydrate and Lipid Metabolism Disorders in Diabetic Mice by Regulating Bile Acid Metabolism via the Gut–Liver Axis

Xue-Xue Zhu, Chen-Yang Zhao, Xin-Yu Meng, Xiao-Yi Yu, Lin-Chun Ma, Tian-Xiao Chen, Chang Chang, Xin-Yu Chen, Yuan Zhang, Bao Hou, Wei-Wei Cai, Bin Du und 3 weitere

Pharmaceuticals · 01.08.2024 · 17 (8) · 1015

DOI: 10.3390/ph17081015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 01.08.2024. Verfasst von Xue-Xue Zhu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China, Jiangsu Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2DM) is a metabolic syndrome characterized by chronic inflammation, insulin resistance, and islet cell damage. The prevention of T2DM and its associated complications is an urgent public health issue that affects hundreds of millions of people globally. Numerous studies suggest that disturbances in gut metabolites are important driving forces for the pathogenesis of diabetes. However, the functions and mechanisms of action of most commensal bacteria in T2DM remain largely unknown.

Methods

The quantification of bile acids (BAs) in fecal samples was performed using ultra-performance liquid chromatography–tandem mass spectrometer (UPLC-MS/MS). The anti-diabetic effects of Bacteroides uniformis (B. uniformis) and its metabolites cholic acid (CA) and chenodeoxycholic acid (CDCA) were assessed in T2DM mice induced by streptozocin (STZ) plus high-fat diet (HFD).

Results

We found that the abundance of B. uniformis in the feces and the contents of CA and CDCA were significantly downregulated in T2DM mice. B. uniformis was diminished in diabetic individuals and this bacterium was sufficient to promote the production of BAs. Colonization of B. uniformis and intragastric gavage of CA and CDCA effectively improved the disorder of glucose and lipid metabolism in T2DM mice by inhibiting gluconeogenesis and lipolysis in the liver. CA and CDCA improved hepatic glucose and lipid metabolism by acting on the Takeda G protein-coupled receptor 5 (TGR5)/adenosine monophosphate-activated protein kinase (AMPK) signaling pathway since knockdown of TGR5 minimized the benefit of CA and CDCA. Furthermore, we screened a natural product—vaccarin (VAC)—that exhibited anti-diabetic effects by promoting the growth of B. uniformis in vitro and in vivo. Gut microbiota pre-depletion abolished the favorable effects of VAC in diabetic mice.

Conclusions

These data suggest that supplementation of B. uniformis may be a promising avenue to ameliorate T2DM by linking the gut and liver.

Schlagwörter

Stichwörter der Autor:innen

AMPKBacteroides uniformisTGR5bile aciddiabetesgut microbiome

Autor:innen und Institutionen

  • Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
  • Department of Physiology, Eberhard-Karls-University of Tübingen, 72074 Tübingen, Germany.
  • Department of Clinical Research Center, Jiangnan University Medical Center, Wuxi 214001, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing 210009, China.

Förderung

  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China
  • Jiangsu Natural Science Foundation
  • JNU
  • Fundamental Research Funds for the Central Universities
  • Medical Discipline Program of Wuxi Health Commission, and the Science and Technology Projects of Wuxi City

Zitieren

APA

Zhu, X. X., Zhao, C. Y., Meng, X. Y., Yu, X. Y., Ma, L. C., Chen, T. X., Chang, C., Chen, X. Y., Zhang, Y., Hou, B., Cai, W. W., Du, B., Han, Z. J., Qiu, L. Y., & Sun, H. J. (2024). Bacteroides uniformis Ameliorates Carbohydrate and Lipid Metabolism Disorders in Diabetic Mice by Regulating Bile Acid Metabolism via the Gut–Liver Axis. Pharmaceuticals, 17(8), 1015. https://doi.org/10.3390/ph17081015

Vancouver

Zhu XX, Zhao CY, Meng XY, Yu XY, Ma LC, Chen TX, et al. Bacteroides uniformis Ameliorates Carbohydrate and Lipid Metabolism Disorders in Diabetic Mice by Regulating Bile Acid Metabolism via the Gut–Liver Axis. Pharmaceuticals. 2024;17(8):1015. doi:10.3390/ph17081015

BibTeX
@article{Zhu2024,
  author = {Zhu, Xue-Xue and Zhao, Chen-Yang and Meng, Xin-Yu and Yu, Xiao-Yi and Ma, Lin-Chun and Chen, Tian-Xiao and Chang, Chang and Chen, Xin-Yu and Zhang, Yuan and Hou, Bao and Cai, Wei-Wei and Du, Bin and Han, Zhi-Jun and Qiu, Li-Ying and Sun, Hai-Jian},
  title = {Bacteroides uniformis Ameliorates Carbohydrate and Lipid Metabolism Disorders in Diabetic Mice by Regulating Bile Acid Metabolism via the Gut–Liver Axis},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {8},
  pages = {1015},
  doi = {10.3390/ph17081015}
}
Kostenlos starten →